Pestalozzi advises Celgene on its investment in Anokion

Anokion SA, a Swiss biotechnology company focused on treating autoimmune disease by restoring normal immune tolerance, completed its $40 million Series B financing. Pestalozzi advised Celgene as to Swiss law.

Pestalozzi Attorneys at Law Ltd.
Zurich – Feldeggstrasse 4 | 8008 Zurich | Switzerland | T +41 44 217 91 11
Geneva – Cours de Rive 13 | 1204 Geneva | Switzerland | T +41 22 999 96 00
www.pestalozzilaw.com